Indeed, low or normal CSF and/or blood levels of NfL in a patient with RPD might exclude with very high certainty the diagnosis of prion disease and induce clinicians to consider other etiologies and to introduce an ex adiuvantibus therapy. This evidence concerns the gene NEFL and prion disease.